Gregory S. Morrison
Lawyers
Filters
FTC clearance of Novo Nordisk acquisition of certain Catalent sites
We secured regulatory approval following a lengthy review
Lightyear GP-led secondary transaction and formation of continuation fund
We advised Lightyear on the secondary transaction and continuation fund formation
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Cano Health amendment and covenant waiver for side-car credit facility
We advised Rubicon Founders in connection with the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Japan Industrial Partners $15.2 billion acquisition of Toshiba
We are advising Japan Industrial Partners on the acquisition
SCANA Special Litigation Committee in nuclear facility investigation
We advised the committee following the abandonment of a multi-billion-dollar nuclear project
Aetna receives DOJ approval of $77 billion acquisition by CVS Health
Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…
Davis Polk Advises Aetna on the U.S. Department of Justice Approval of Its Acquisition by CVS Health
Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…